Erythropoiesis-stimulating agents (ESAs) are genetically engineered forms of erythropoietin that stimulate erythropoiesis through direct or indirect action on the erythropoietin receptor producing an increase
Michael Marlon Mohundro, PharmD
Advertisement
Articles by Michael Marlon Mohundro, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma
2
Zipalertinib Plus Chemotherapy Improves PFS in First-Line EGFR Exon 20 Insertion+ NSCLC
3
Dr Van Gorp on PFS Data With TUB-040 in Platinum-Resistant Ovarian Cancer
4
Neoadjuvant Ivonescimab Plus Chemotherapy Yields pCRs in Resectable HNSCC
5